To test this at the level of gene expression, we used the mSigDB cell-type-specific signature collection (C8), supplemented with a signature that we derived from SMARCB1 re-introduction experiments in rhabdoid tumor cell lines.31 This evidence concerns the gene SMARCB1 and rhabdoid tumor.